Nickname | IMF |
---|---|
Formation | 1990 |
Founder |
|
Type | Non-profit organization |
Legal status | 501(c)(3) |
Purpose | cancer research, patient education |
Headquarters | North Hollywood, California, US |
Website | myeloma |
The International Myeloma Foundation (IMF) is an American non-profit organization serving patients with myeloma, a cancer of plasma cells in the bone marrow. The IMF also provides support and information for family members, caregivers of myeloma patients, physicians and nurses. The organization is dedicated to improving the quality of life for all myeloma patients by focusing on four key areas: research, education, support, and advocacy.
Founded in 1990 by Brian Novis, Susie Novis, and Brian G.M. Durie, IMF is a 501(c)(3) resource for both patients and caregivers, offering programs that include educational seminars, a patient hotline, multilingual publications, government advocacy, and a web-based Personal Information Management system for recording care and treatment.
The IMF is based in North Hollywood, California, and, according to its 2018 annual report, has a membership of 525,000 people in 140 countries. [1] Its motto is "Improving lives — Finding the cure".
The IMF was founded in 1990 by Brian Novis, who was diagnosed with multiple myeloma at age 33, his wife Susie Novis, and his physician Brian G.M. Durie.
Brian Novis died of myeloma in 1992, but the IMF's work continues with Susie Novis serving as President and Durie as Chair of the Board of Directors. [2]
There are approximately 32,110 new patients diagnosed with myeloma each year in the U.S. [3] The IMF offers a variety of programs to aid with educating all new patients and their caregivers.[ citation needed ]
In 1993, the IMF became the first organization to offer Patient & Family Seminars, granting patients and their caregivers' access to doctors working in the field of myeloma. US-based seminars have been held in Boca Raton, Florida; Seattle, Washington; Boston, Massachusetts; and Los Angeles, California. Internationally based seminars have been held in the Czech Republic, Denmark, Germany, France, Austria, Norway, Slovakia and Italy. [1]
To address the need for similar events in smaller communities, the IMF also hosts Regional Community Workshops and Myeloma Center Workshops. US Regional Community Workshops have been held in North Carolina, Georgia, Texas, Indiana, Arkansas, Kansas and Wisconsin. Internationally based seminars have been held in Germany, Italy and the Czech Republic. [1]
The IMF produces a number of publications, which are regularly updated and offered free of charge both in print and digitally on the IMF website. The IMF library of publications provides information related to myeloma, including innovations in treatment and information on clinical trials. IMF also produces an InfoPack, which is made up of a selection of the IMF’s publications and is designed to provide newly diagnosed patients and their families with an understanding of the disease and care. [1]
The IMF worked with the Association of Cancer Online Resources (ACOR) to create a myeloma mailing list an amyloid mailing list to facilitate information exchange and support. [4] The IMF also hosts a hotline at 800-452-CURE (2873 and offers online help at www.myeloma.org. [5]
The IMF has an advocacy group (the Myeloma ACTION Team) that guides individuals in taking a stand about critical health issues affecting the myeloma community. [6]
The IMF is involved in a variety of research efforts, which include maintaining a myeloma gene and tissue bank project.
The IMF created the Brian D. Novis Research Grant in 1994 as part of its commitment to finding a cure for myeloma. Novis was the co-founder of IMF and in his memory, the organization promotes research of better treatments, management, prevention, and a cure. The grants are made possible through donations from private individuals and are awarded to doctors and researchers in the field of myeloma, as well as related disorders including but not limited to MGUS (monoclonal gammopathy of undetermined significance) and immunoglobulin derived amyloidosis. [7]
A subsidiary is the International Myeloma Working Group (IMWG), a consortium of more than 100 myeloma researchers from around the world who collaborate on a broad range of myeloma projects. Members of the IMWG conduct research to prevent onset of myeloma, improve treatment and find a cure. [8] The working group publishes statements and treatment guidelines in its own name [9] as well as sponsoring publications by its members.
The IMF also has the Black Swan Research Initiative (BSRI) in order to work towards finding a cure for myeloma. [10]
The organization holds its major fundraising event, the annual Comedy Celebration benefiting the Peter Boyle Memorial fund, in November of each year. [11]
In the United States, IMF is categorized as a 501(c) non-profit organization by the IRS.
Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Often, no symptoms are noticed initially. As it progresses, bone pain, anemia, renal insufficiency, and infections may occur. Complications may include hypercalcemia and amyloidosis.
Kathy Giusti is a business leader and a healthcare disrupter. She is a two-time cancer survivor having been diagnosed with multiple myeloma and breast cancer. Kathy Co-Founded the Multiple Myeloma Research Foundation where she was CEO and president for nearly two decades. She also co-chaired the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, which she helped found, as a Senior Fellow at Harvard Business School.
The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 58,000 members in 142 countries and territories. The mission of the AACR is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
The Asthma and Allergy Foundation of America (AAFA) is the leading patient organization for people with asthma and allergies and the oldest asthma and allergy patient group in the world. AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education, advocacy, and support.
The National Coalition for Cancer Survivorship (NCCS) is a 501(c)(3) nonprofit organization cancer advocacy organization based in Silver Spring, Maryland. It is the oldest survivor-led cancer advocacy organization in the country, and works to effect policy change at the national level.
The American Sexual Health Association (ASHA), formally known as the American Social Hygiene Association and the American Social Health Association, is an American nonprofit organization established in 1914, that cites a mission to improve the health of individuals, families, and communities, with an emphasis on sexual health, as well as a focus on preventing sexually transmitted infections and their harmful consequences. ASHA uses tools such as education, communication, advocacy and policy analysis activities with the intent to heighten public, patient, provider, policymaker and media awareness of STI prevention, screening, diagnosis and treatment strategies.
The Arthritis Foundation is a nonprofit organization addressing the needs of people living with arthritis in the United States.
The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.
The Leukaemia Foundation is a national charity in Australia dedicated to helping people who have been diagnosed with leukaemia, lymphoma, myeloma, MDS, MPN, Waldenström's macroglobulinaemia, aplastic anaemia, or amyloidosis.
The National Health Council (NHC) is a nonprofit association of health organizations.
TheSkin Cancer Foundation (SCF), founded in 1979, aims to "empower people to take a proactive approach to daily sun protection and the early detection and treatment of skin cancer." The organization has developed a mix of programs and resources that serve the needs of a diverse audience. SCF disseminates information via its digital resources, public service campaigns and community programs, including Destination: Healthy Skin. The foundation's professional membership includes dermatologists, Mohs surgeons, plastic surgeons and other medical professionals working to fight skin cancer. Headquartered in New York City, the foundation is a 501(c)(3) public charity.
Myeloma Canada is the only national non-profit organization uniquely devoted to the Canadian myeloma community. The organization helps myeloma patients and raises awareness about this rare form of cancer.
The Pancreatic Cancer Action Network (PanCAN) is a United States-based 501(c)(3) charity that funds research, provides patient/caregiver support, conducts community outreach and advocates for increased federal research funding for those affected by pancreatic cancer.
The Cancer Prevention and Treatment Fund is a Washington D.C.-based nonprofit program that is part of the National Center for Health Research, founded in 1999. The president is Diana Zuckerman.
The Lustgarten Foundation is a 501(c)(3) non-profit organization foundation dedicated to advancing the research related to the diagnosis, treatment, cure and prevention of pancreatic cancer while raising public awareness and providing support to patients and their families. The Foundation is the largest private funder of pancreatic cancer research in the world. Based in Woodbury, Nassau County, New York, the Foundation's mission is to cure pancreatic cancer by funding scientific and clinical research related to the diagnosis, treatment, and prevention of pancreatic cancer; providing research information and clinical support services to patients, caregivers and individuals at high risk; and increasing public awareness and hope for those dealing with this disease. Increasing funding and support of research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of pancreatic cancer; Facilitating and enhancing the dialogue among members of the medical and scientific communities about basic and clinical research efforts that relate to pancreatic cancer; Heightening public awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for pancreatic cancer patients, their families, and friends.
Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.
Smouldering myeloma is a disease classified as intermediate in a spectrum of step-wise progressive diseases termed plasma cell dyscrasias. In this spectrum of diseases, a clone of plasma cells secreting monoclonal paraprotein causes the relatively benign disease of monoclonal gammopathy of undetermined significance. This clone proliferates and may slowly evolve into more aggressive sub-clones that cause smouldering multiple myeloma. Further and more rapid evolution causes the overtly malignant stage of multiple myeloma and can subsequently lead to the extremely malignant stage of secondary plasma cell leukemia. Thus, some patients with smouldering myeloma progress to multiple myeloma and plasma cell leukemia. Smouldering myeloma, however, is not a malignant disease. It is characterised as a pre-malignant disease that lacks symptoms but is associated with bone marrow biopsy showing the presence of an abnormal number of clonal myeloma cells, blood and/or urine containing a myeloma protein, and a significant risk of developing into a malignant disease.
Gulshan Rai Khatri was an Indian medical doctor and public health specialist, known for his efforts in curbing the disease of tuberculosis worldwide. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. In 2018, he was diagnosed with multiple myeloma, a form of blood cancer and after a long array of health problems, he succumbed to a heart and lung seizure on July 16, 2020.
Inspire is an Arlington, Virginia-based healthcare social network. It builds and manages online health communities for patients and caregivers, and connects patients to life science companies for the purpose of research.
Brian G.M. Durie is a Scottish hematologist known for his research and efforts regarding multiple myeloma and blood disorders, especially his development of the multiple myeloma staging system. He is the chairman of the board and Scientific Director for the Myeloma Foundation and a specialist in multiple myeloma and related disorders at the Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute ..